Boya Stem Cell Technology Co. Ltd. develops stem cell technology products. The company is headquartered in Wuxi, China.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Shenzhen Boya Perception Medical Technology Co., Ltd., established on 2019-09-25, Business scope includes general business items:Medical Device Development,consultation service;Sales of Medical Devices(Operate with a valid license);biomedicine,Biological product,biomaterials,Research and development of biotechnology,technology transfer,technical consulting,Technical Services;Internet of things and information system development,Sales,consultation service;Biotechnology training services for adults(Does not include certification,Does not include nationally recognized vocational certificate training);computer basic software,Application software development,Sales,consultation service;system integration;Self-operated and agent biological products,Import and export of beauty products and biotechnology(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export);Communication Engineering Design,construction;Intelligent Building Engineering Design,construction.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments),The licensing program is:

Baxter Healthcare SA engages in the development, production, and sale of healthcare systems and products. It also acquires and manages participations in pharmaceutical-chemical firms. The company was founded on December 7, 2000 and is headquartered in Glattpark, Switzerland.

Green Cross Co., Ltd. engages in the manufacture, sale, and rental of safety items. Its products include road safety materials, disaster prevention necessities, safety equipment, protection gear, and signboards and tags. The company was founded in January 1969 and is headquartered in Fukuoka, Japan.

Morinaga Milk Industry Co., Ltd. engages in the production and distribution of dairy products. Its operations are carried out through the following segments: Food Products and Others. The Food Products segment engages in the production and sale of milk, dairy-based beverages, yogurt, desserts, condensed milk, powdered milk, butter, cheese, ice cream, non-dairy beverages (juice, tea, coffee), and clinical liquid diets. The Others segment provides the real estate leasing services. It also engages in the manufacture and sale of animal feeds; design and construction of plant equipment. The company was founded on September 1, 1917 and is headquartered in Tokyo, Japan.

University Health Network (UHN) is a healthcare and medical research organization in Toronto, Ontario, Canada. It is the largest such research organization in Canada and North America, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource in 2015, 2016 and 2017. It was created in 1986 by the Government of Ontario through the merger of four major hospitals: Toronto General Hospital, Toronto Western Hospital, with the Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute merged in with The Toronto Hospital in 1999 and the name changed to the University Health Network. All four hospitals are affiliated with the Faculty of Medicine at the University of Toronto and serve as teaching hospitals for resident physicians, nurses, and other healthcare professions. UHN also operates The Michener Institute, an applied health sciences college that opened in 1958.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

Shanghai Lanqiao Biotechnology Co., Ltd., established on 2019-08-02, Business scope includes licensed projects:Production of Class II Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Own Equipment Rental,Import and export,Technology Import and Export,Production of Class I Medical Devices,Class I medical device,Class II medical device,plastic products,Equipment,electrical equipment,Chemical products and raw materials(Hazardous Chemicals,Monitor Chemicals,precursor chemicals,Civilian Explosives Excluded),Computer hardware and software and auxiliary equipment,electronic product,Sales of communication equipment,literary creation;Advertising Design,acting,make,advertising(non-broadcasting station,television station,Newspaper Publishing Unit);software development;Special Equipment Repair.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine, and oncology. Samumed adopted a fresh operating philosophy from the beginning — one based on a goal of building a broad technology platform aimed at modulating regenerative pathways to improve patient health.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Guangzhou Ruibei Medical Technology Co., Ltd., established on 2017-01-03, Business scope includes medical research and experimental development;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Mechanical equipment research and development;Biochemical product technology research and development;Information Technology Consulting Services;Instrument sales;Optical Instrument Sales;Teaching equipment sales;Instrument Repair;Manufacturing of experimental analysis instruments;Chemical product sales(No licensed chemical products);Sales of Class II Medical Devices;Sales of Class I Medical Devices;Medical equipment rental;Technology intermediary service;Experimental analysis instrument sales;Laboratory animal cage sales;software sales;software development;Instrument Manufacturing;Inspection and testing service;Import and export;Import and export agency;Technology Import and Export;Class III medical device business;Drug retail;Experimental animal management

Shanghai Huanyi Biological Technology Co., Ltd. is a Chinese company located in Shanghai that develops integrated multi-omics data generation and computational platforms. The firm was founded in 2019.

The Research Authority serves as the administrative and financial framework for research activities, scientific experiments and technical analyses carried out by Technion faculty, and TRDF staff. The missions of the Research & Development Division are: - Location, collection, processing and distribution of information concerning local and international research funding - Assistance in locating appropriate funding sources for Technion researchers - R&D information management services and in-campus marketing - Guidance and administrative services for Technion researchers in submitting research proposals to granting agencies and business entities - Management of contractual engagements with granting agencies and business entities - Contractual and budgetary administration of research grants and other accounts

Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.